Expanding diagnostic capabilities into two new medical conditions – Hemorrhagic Stroke and Aneurysm

Building robust medical software requires rigorous science, strong backing, and continuous innovation. We are excited to share an update on our ongoing research and development as we expand our diagnostic capabilities into two critical medical conditions:

🧠  1. Hemorrhagic Stroke: research and development are actively underway. To ensure the highest accuracy and safety, we are currently gathering and analyzing additional clinical data to train and validate our algorithms.

🔴 2. Aneyrism: Thanks to recent financial support from state funding, our dedicated team officially kicked off this new project this August! Our goal is to complete the development and deliver this vital diagnostic tool by the summer of next year.

These milestones reflect our ongoing commitment to expanding the clinical utility of SINAPSE and bringing high-impact solutions to the global healthcare market.